Endolysins and membrane-active peptides: innovative engineering strategies against gram-negative bacteria
Top Cited Papers
Open Access
- 3 June 2025
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 16, 1603380
Abstract
Endolysins, bacteriophage-encoded peptidoglycan hydrolases, offer promising potential in antibacterial therapy, including treatments targeting gram-negative bacteria. While these enzymes naturally act primarily on gram-positive bacteria, their application against gram-negative pathogens is more challenging due to the presence of a dual-layer cell membrane, which acts as a protective barrier. However, innovative approaches, such as fusing endolysins with antimicrobial peptides (AMPs), have demonstrated increased efficacy against gram-negative bacteria. Modifying endolysins by introducing hydrophobic properties or positive charges or combining them with agents that disrupt the outer membrane enhances their bactericidal activity. Moreover, phage endolysins that exhibit activity against gram-negative bacteria are a promising source of membrane-active peptides. Identifying new peptide sequences derived from endolysins capable of penetrating the bacterial cell membrane represents a novel and increasingly explored research direction. Studying these innovative strategies had yielded promising results, though the field remains under active investigation and development. Ongoing efforts aim to optimize these approaches to improve their effectiveness against antibiotic-resistant gram-negative bacterial strains, which are particularly difficult to treat with conventional antibiotics. This review summarizes the latest advancements and solutions in the field, highlighting the potential of endolysins and membrane-active peptides as next-generation antibacterial agents.Keywords
This publication has 130 references indexed in Scilit:
- Discovery of Antimicrobial Lysins from the “Dark Matter” of Uncharacterized Phages Using Artificial IntelligenceAdvanced Science, 2024
- Assessing the synergistic potential of bacteriophage endolysins and antimicrobial peptides for eradicating bacterial biofilmsArchives of Microbiology, 2024
- Bacteriophage Endolysin: A Powerful Weapon to Control Bacterial BiofilmsThe Protein Journal, 2023
- Characterization of a broad-spectrum endolysin rLysJNwz and its utility against Salmonella in foodsApplied Microbiology and Biotechnology, 2023
- Current Treatment Strategies Against Multidrug-Resistant Bacteria: A ReviewCurrent Microbiology, 2022
- Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysinJournal of Microbiology, 2022
- The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularlyAntonie van Leeuwenhoek, 2017
- The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal regionJournal of Microbiology, 2017
- Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminusAntonie van Leeuwenhoek, 2016
- Characterization of five novel endolysins from Gram-negative infecting bacteriophagesApplied Microbiology and Biotechnology, 2012